After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Change Management to Registered Medical Devices will be proceeded for endorsement at The GHWP 28th Annual Meeting.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) devices for the Medical Device Manufacturer or its Authorized Representative will be proceeded for endorsement at The GHWP 28th Annual Meeting.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Adverse Event Reporting Guidance for the Medical Device Manufacturer or its Authorized Representative will be proceeded for endorsement at The GHWP 28th Annual Meeting.

Please have the attached Annual Meeting Pragramme (Day 1- Day 4) of GHWP 28th Annual Meeting and 28th GHWP Technical Committee Meeting to be held 9th - 12th December 2024, in Kuala Lumpur of Malaysia.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Amendment 11 to GHWP House Rules will be proceeded for endorsement at The GHWP 28th Annual Meeting.